Oncology/Hematology

Skin Cancer

Latest AI and machine learning research in skin cancer for healthcare professionals.

8,155 articles
Stay Ahead - Weekly Skin Cancer research updates
Subscribe
Browse Categories
Showing 64-84 of 8,155 articles
Governing artificial intelligence in cancer care: Perspectives and recommendations from patient organizations and the MULTIR consortium.

BACKGROUND: Artificial intelligence (AI) has the potential to improve cancer care. Its implementatio...

(1)
Sep 2026 42697525
CLDN18 as a novel junctional biomarker enhancing multi-gene classification of pancreatic cancer.

Pancreatic adenocarcinoma (PAAD) remains one of the most lethal cancers, largely due to the lack of ...

(2)
Sep 2026 42691511
Targeting GLUTs in Cancer: Mechanisms, Combination Strategies, and Translational Challenges.

Cancer cells exhibit metabolic reprogramming, most notably the Warburg effect, which underscores the...

(5)
Sep 2026 42678477
Artificial intelligence-assisted design of MAGE-A4 Ă—CD16 T-cell receptor-like natural killer cell engagers.

The cancer-testis antigen MAGE-A4 is an attractive immunotherapy target due to its high expression i...

(2)
Aug 2026 42675026
Integrated pan-cancer analysis reveals a cancer-associated fibroblast oxidative stress response signature predicting immunotherapy response and prognosis.

Oxidative stress plays a significant regulatory role in tumor immune responses and can influence the...

(2)
Aug 2026 42671485
Silencing SLC52A2 promotes tertiary lymphoid structure formation and inhibits IL-17 pathway to ameliorate melanoma progression.

Tertiary lymphoid structure (TLS) correlates with improved prognosis in melanoma. The role of solute...

(2)
Aug 2026 42671664
Artificial intelligence for translational personalized neoantigen cancer vaccine development.

Personalized neoantigen cancer vaccine is a promising strategy for precision immunotherapy by target...

(1)
Aug 2026 42675475
Microphysiological immune-on-chip systems: engineering human immunity for precision immunotherapy, vaccine development, and autoimmune disease modelling.

Microphysiological immune-on-chip systems have emerged as transformative biomedical microdevices cap...

(2)
Aug 2026 42663717
Lactylation-related immune-metabolic dysregulation defines prognostic and therapeutic stratification in lung adenocarcinoma.

BACKGROUND: Lactylation links lactate metabolism with inflammatory signaling and immune regulation i...

(2)
Aug 2026 42664787
A p53R273H-selective bispecific T cell engager: Computational design and functional validation.

TP53 mutations occur in over 50% of human cancers and generate shared neoantigens, including p53R273...

(3)
Aug 2026 42756525
Thymic radiation is associated with worse outcomes in patients with NSCLC.

BACKGROUND: Emerging evidence indicates the functional importance of the thymus in adult health and ...

(1)
Aug 2026 42641684
Uncoupling Type I Interferon Benefits From Inflammatory Toxicity: Transformer-Prioritized Precision Agonists for Potent and Safer Cancer Immunotherapy.

Paclitaxel (PTX) chemotherapy is constrained by an "immunomodulatory paradox," where antitumor Type ...

(3)
Aug 2026 42635620
Artificial intelligence (AI)-enabled platforms for cancer vaccine engineering.

Cancer vaccines are emerging as a promising approach in immuno-oncology, with the potential to gener...

(3)
Aug 2026 42637140
Multi-omics integration and machine learning define an iron-sulfur cluster/zinc-binding protein prognostic signature in esophageal squamous cell carcinoma.

Esophageal squamous cell carcinoma (ESCC) is characterized by substantial intratumoral heterogeneity...

(1)
Aug 2026 42637882
CDKN3, PKP2, ADM, MS4A1, FAM83A, and DKK1 Define a Posttranslational Modification (PTM)-Associated Prognostic Model for Lung Adenocarcinoma.

INTRODUCTION: Posttranslational modification (PTM) plays an important role in protein regulation and...

(2)
Aug 2026 42638932
AI for tumour proportion scoring of programmed death-ligand 1 immunohistochemistry in non-small cell lung cancer: a review of commercial and non-commercial tools.

Programmed death-ligand 1 (PD-L1) expression, commonly quantified as tumour proportion score (TPS), ...

(2)
Aug 2026 42634001
Neoantigen in cancer immunotherapy: mechanism, therapeutic strategies and future perspectives.

Neoantigens are tumor-specific antigens resulting from genetic, transcriptomic, and proteomic change...

(5)
Aug 2026 42632040
A deep learning-derived risk score model from digital pathology to forecast nivolumab outcomes in gastric carcinoma.

BACKGROUND: The PD-L1 combined positive score (CPS) is a biomarker predicting responses in gastric c...

(1)
Aug 2026 42629440
RNA splicing in health and disease.

RNA splicing expands the functional output of eukaryotic genomes by enabling individual precursor me...

(1)
Aug 2026 42625101
Browse Categories